IP Library Assignment 060121/0591
Patent Assignment
Reel/Frame 060121/0591

Amended and Restated Patent Security Agreement

Recorded: 2022-05-19 Pages: 8
Assignor
UROGEN PHARMA LTD.
Executed: 2022-05-19
Assignee
RTW INVESTMENTS ICA V
TEN EARLSFORT TERRACE, DUBLIN 2, D02 T380, IRELAND
Covered Properties (12)
Biocompatible Drug Delivery Apparatus and Methods
Patent: 8,361,490 →
Application: 10/941,942 →
Publication: US 2006/0057208
Material and Method for Treating Internal Cavities
Patent: 9,040,074 →
Application: 13/553,198 →
Publication: US 2013/0046275
Methods for Treatment of Bladder Cancer
Patent: 9,011,411 →
Application: 13/726,162 →
Publication: US 2013/0110030
Slow Release Formulations of Cell Cycle Regulators and Anti-Cancer Agents for Local Treatment of Solid Cancer
Patent: 9,801,854 →
Application: 14/600,354 →
Material and Method for Treating Internal Cavities
Application: 14/720,676 →
Publication: US 2015/0366974
Systems and Methods for Improved Communication Efficiency in Wireless Networks
Patent: 9,844,028 →
Application: 14/825,944 →
Publication: US 2016/0050666
Material and Method for Treating Internal Cavities
Patent: 9,950,069 →
Application: 15/366,256 →
Publication: US 2017/0112935
Production of Thermoreversible Hydrogels for Therapeutic Applications
Application: 15/427,341 →
Publication: US 2017/0143833
Material and Method for Treating Internal Cavities
Application: 16/518,511 →
Publication: US 2020/0114008
Material and Method for Treating Cancer
Application: 17/546,204 →
Publication: US 2022/0202773
Material and Method for Treating Internal Cavities
Application: 17/566,882 →
Publication: US 2022/0118096
Material and Method for Treating Internal Cavities
Application: 63/124,111 →
Related Assignments (21)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Sep 16, 2004
From: HOLZER, ASHER; DANIEL, DORIT; HIRSZOWICZ, ERAN
To: THERACOAT LTD.
Reel/Frame 015817/0081 →
Assignment of Assignor's Interest Nov 5, 2012
From: HOLZER, ASHER; DANIEL, DORIT; MULLERAD, MICHAEL; DE LA ZERDA, JAIME
To: THERACOAT LTD.
Reel/Frame 029238/0909 →
Assignment of Assignor's Interest Jun 13, 2013
From: HOLZER, ASHER; DANIEL, DORIT; HIRSZOWICZ, ERAN
To: THERACOAT LTD.
Reel/Frame 030605/0477 →
Change of Name Jan 19, 2016
From: THERACOAT LTD.
To: UROGEN PHARMA LTD.
Reel/Frame 037553/0678 →
Assignment of Assignor's Interest Feb 3, 2016
From: YANG, LIN; CHEN, JIALING LI; VERMANI, SAMEER; TIAN, BIN
To: QUALCOMM INCORPORATED
Reel/Frame 037654/0933 →
Assignment of Assignor's Interest Jan 8, 2018
From: HOLZER, ASHER; DANIEL, DORIT; MULLERAD, MICHAEL; DE LA ZERDA, JAIME
To: THERACOAT LTD.
Reel/Frame 044556/0637 →
Change of Name Jan 8, 2018
From: THERACOAT LTD.
To: UROGEN PHARMA LTD.
Reel/Frame 045016/0287 →
Assignment of Assignor's Interest Jan 30, 2018
From: DE LA ZERDA, JAIME; DOLLBERG, YOSH; SHPOLANSKY, URI; MALCHI, NADAV
To: THERACOAT LTD.
Reel/Frame 045194/0256 →
Change of Name Jan 30, 2018
From: THERACOAT LTD.
To: UROGEN PHARMA LTD.
Reel/Frame 045194/0379 →
Change of Name Mar 15, 2021
From: THERACOAT LTD.
To: UROGEN PHARMA LTD.
Reel/Frame 055588/0095 →
Security Interest Apr 8, 2021
From: UROGEN PHARMA LTD.
To: RTW INVESTMENTS ICAV
Reel/Frame 055868/0385 →
Assignment of Assignor's Interest Oct 22, 2021
From: KONORTY, MARINA
To: UROGEN PHARMA LTD.
Reel/Frame 057874/0867 →
Security Interest Mar 18, 2022
From: UROGEN PHARMA LTD.
To: BIOPHARMA CREDIT PLC
Reel/Frame 059302/0501 →
Assignment of Assignor's Interest Apr 7, 2022
From: HIONIDI, YULIA; TSIPORI, OMER; KONORTY, MARINA
To: UROGEN PHARMA LTD.
Reel/Frame 059528/0317 →
Assignment of Assignor's Interest Apr 29, 2022
From: KONORTY, MARINA
To: UROGEN PHARMA LTD.
Reel/Frame 059774/0318 →
Assignment of Assignor's Interest May 2, 2022
From: KONORTY, MARINA
To: UROGEN PHARMA LTD.
Reel/Frame 059760/0394 →
Patent Security Agreement Aug 18, 2023
From: UROGEN PHARMA LTD.
To: BIOPHARMA CREDIT PLC
Reel/Frame 064641/0263 →
Patent Security Agreement Mar 18, 2024
From: UROGEN PHARMA LTD.
To: BIOPHARMA CREDIT PLC
Reel/Frame 066805/0346 →
Amended and Restated Patent Security Agreement Mar 6, 2025
From: UROGEN PHARMA LTD.
To: BIOPHARMA CREDIT PLC [COLLATERAL AGENT]
Reel/Frame 070434/0319 →
Amended and Restated Patent Security Agreement Aug 18, 2025
From: UROGEN PHARMA LTD.
To: BIOPHARMA CREDIT PLC, AS COLLATERAL AGENT
Reel/Frame 072472/0233 →
Second Amended and Restated Patent Security Agreement Mar 2, 2026
From: UROGEN PHARMA LTD.
To: BIOPHARMA CREDIT PLC, AS COLLATERAL AGENT
Reel/Frame 074994/0338 →